Articles by Disease (Leukoencephalopathies)

Silencing the Brain May be Better than Stimulating it. The GABA Effect

Journal: Current Pharmaceutical Design
Volume: 20
Page: 4154-4166
Author(s): Francesca Pistoia, Marco Sara, Simona Sacco, Marco Franceschini and Antonio Carolei

Personalization of Targeted Therapy in Advanced Thyroid Cancer

Journal: Current Genomics
Volume: 15
Page: 190-202
Author(s): Poupak Fallahi, Silvia Martina Ferrari, Valeria Mazzi, Roberto Vita, Salvatore Benvenga and Alessandro Antonelli

Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 13
Page: 134-143
Author(s): Lorena Lorefice, Giuseppe Fenu, Jessica Frau, Giancarlo Coghe and Maria Giovanna Marrosu

The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 13
Page: 121-127
Author(s): Eric Toussirot and Matthieu Bereau

The Vascular Component of Alzheimer`s Disease

Journal: Current Neurovascular Research
Volume: 11
Page: 168-176
Author(s): Dafin Fior Muresanu, Aurel Popa-Wagner, Adina Stan, Ana-Maria Buga and Bogdan Ovidiu Popescu

Alzheimer Biomarkers and Clinical Alzheimer Disease were Not Associated with Increased Cerebrovascular Disease in a Memory Clinic Population

Journal: Current Alzheimer Research
Volume: 11
Page: 40-46
Author(s): Petra E. Spies, Marcel M. Verbeek, Magnus J.C. Sjogren, Frank-Erik de Leeuw and Jurgen A.H.R Claassen

Relationships Between White Matter Hyperintensities, Cerebral Amyloid Angiopathy and Dementia in a Population-based Sample of the Oldest Old

Journal: Current Alzheimer Research
Volume: 10
Page: 1090-1097
Author(s): M Tanskanen, RN Kalaria, I-L Notkola, M Mäkelä, T Polvikoski, L Myllykangas, R Sulkava, H Kalimo, A Paetau, P Scheltens, F Barkhof, van Straaten ECW and T Erkinjuntti